Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Aveanna Healtcare reports in-line earnings, revenue beat in Q4; Stock up 3.5%

EditorRachael Rajan
Published 03/14/2024, 07:04 AM
Updated 03/14/2024, 07:04 AM
© Reuters.

ATLANTA - Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) announced its fourth-quarter financial results, showcasing a revenue increase and meeting earnings per share (EPS) expectations. The company reported a Q4 EPS of -$0.02, aligning with analyst estimates.

Revenue for the quarter was reported at $478.8 million, surpassing the consensus estimate of $464.99 million and marking a 6.1% increase compared to the same quarter last year.

Following the announcement, the stock rose 3.5% in premarket trading.

The company's gross margin saw a significant rise of 15.3% to $148.4 million compared to Q4 of the previous year. Despite this, Aveanna experienced a net loss of $25.7 million, which is a notable improvement from the net loss of $237.8 million in the comparable period last year. The reduced net loss is primarily due to a substantial non-cash goodwill impairment charge recorded in Q4 2022. Adjusted EBITDA for the quarter also increased by 30.4% to $38.7 million.

Looking ahead, Aveanna forecasts full-year 2024 revenue to be between $1.96 billion and $1.98 billion. This guidance range's midpoint of $1.97 billion is in line with analyst consensus. Adjusted EBITDA expectations for the full year 2024 are set between $146 million and $150 million.

Jeff Shaner, Chief Executive Officer, attributed the strong quarter to the company's strategic transformation and expansion as a value-based homecare provider. He expressed pride in the team's efforts and the solid results produced, which support the company's positive outlook for 2024.

The company's financial health is further evidenced by its liquidity position, with $43.9 million in cash and an undrawn revolver providing approximately $168.1 million of borrowing capacity. Fiscal year-to-date 2023 net cash provided by operating activities was $22.7 million, and free cash flow stood at $12.5 million for the year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Aveanna's CFO, Matt Buckhalter, highlighted the 6.1% growth in revenue and 30.4% growth in Adjusted EBITDA compared to the prior year period. He emphasized the strategic initiatives that have positively impacted the company's cash flow from operations in 2023 and expressed confidence in the momentum heading into 2024.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.